March 14, 2023 (revised) Matthew Winton, PhD Dear Matthew:Inozyme Pharma, Inc. • May 9th, 2023 • Pharmaceutical preparations • Massachusetts
Company FiledMay 9th, 2023 Industry JurisdictionOn behalf of Inozyme Pharma Inc. (the “Company”), I am pleased to offer you employment with the Company. The purpose of this letter (the “Letter Agreement”) is to summarize the terms of your employment with the Company, should you accept our offer:
March 2, 2022 Sanjay S. Subramanian Dear Sanjay:Inozyme Pharma, Inc. • May 10th, 2022 • Pharmaceutical preparations • Massachusetts
Company FiledMay 10th, 2022 Industry JurisdictionOn behalf of Inozyme Pharma Inc. (the “Company”), I am pleased to offer you employment with the Company. The purpose of this letter (the “Letter Agreement”) is to summarize the terms of your employment with the Company, should you accept our offer:
January 29, 2021 Deborah Wenkert, MD Dear Debbie:Inozyme Pharma, Inc. • March 25th, 2021 • Pharmaceutical preparations • California
Company FiledMarch 25th, 2021 Industry JurisdictionOn behalf of Inozyme Pharma Inc. (the “Company”), I am pleased to offer you employment with the Company, commencing on February 2, 2021 (the “Effective Date”). Until the Effective Date, the Consulting Agreement, dated October 29, 2020, by and between the Company and Wenkert & Young, LLC (the “Consulting Agreement”), will remain in full force and effect and continue to govern your provision of services to the Company and you and the Company mutually agree that the Consulting Agreement will terminate on the Effective Date. This letter agreement (the “Letter Agreement”) sets forth the terms of your employment with the Company, should you accept our offer.